Merck & Co Inc (NYSE:MRK)

88.72
Delayed Data
As of 6:30pm ET
 -0.13 / -0.15%
Today’s Change
70.89
Today|||52-Week Range
89.24
+16.11%
Year-to-Date
MRK Regular Dividend: MRK will begin trading ex-dividend on 12/13/19 with a $0.61 dividend payable to shareholders of record as of 12/16/19.
What Happened in the Stock Market Today
5:05pm / MotleyFool.com - Paid Partner Content
Is Clovis Oncology Really a Buyout Candidate?
Dec 03 / MotleyFool.com - Paid Partner Content
Why ArQule Shares Are Skyrocketing Today
11:19am / MotleyFool.com - Paid Partner Content
3 Top Growth Stocks to Buy in December
Dec 03 / MotleyFool.com - Paid Partner Content
Merck Isn't Too Reliant on Keytruda Yet, and That's Good News for Investors
Dec 03 / MotleyFool.com - Paid Partner Content
Here's Why Lexicon Pharmaceuticals Is Tumbling Today
Dec 02 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close88.85
Today’s open88.90
Day’s range88.20 - 89.00
Volume7,730,032
Average volume (3 months)8,322,217
Market cap$226.2B
Data as of 6:30pm ET, 12/09/2019

Growth & Valuation

Earnings growth (last year)+165.32%
Earnings growth (this year)+18.79%
Earnings growth (next 5 years)+8.90%
Revenue growth (last year)+6.17%
P/E ratio24.8
Price/Sales4.82
Price/Book8.63

Competitors

 Today’s
change
Today’s
% change
PFEPfizer+0.03+0.08%
NVSNovartis+0.46+0.50%
BMYBristol-Myers Squibb+1.33+2.22%
ABBVAbbVie-0.54-0.62%
Data as of 6:30pm ET, 12/09/2019

Financials

Next reporting dateFebruary 5, 2020
EPS forecast (this quarter)$1.16
Annual revenue (last year)$42.4B
Annual profit (last year)$6.2B
Net profit margin14.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Kenilworth, New Jersey

Forecasts